Who We Are

Established in 1994, Pharmaniaga has evolved to become one of Malaysia’s largest listed integrated pharmaceutical groups. Our participation in the sector spans across the pharmaceutical value chain from research and development to the production of generic drugs, over-the-counter medicines, logistics and distribution, sales and marketing. In 2021, we made history by becoming the first Malaysian pharmaceutical company to fill and finish manufacture a human vaccine.

 

Already a formidable player in the domestic market, we continue to explore the strategic expansion of our international reach.

2022 KEY HIGHLIGHTS

RM 3.5

BILLION

REVENUE

RM 605.1

MILLION

LOSS AFTER TAXATION

1.9

SEN

DIVIDEND PER SHARE

RM 24.1

MILLION

ZAKAT

3,642

EMPLOYEES

(99.6% LOCAL)

23,957

COVID-19 SWAB TESTS CONDUCTED ON EMPLOYEES

2022 KEY ACHIEVEMENTS